Ligand validation:3RUC

UD2: URIDINE-DIPHOSPHATE-N-ACETYLGALACTOSAMINE

UD2 is a Ligand Of Interest in 3RUC designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3RUC_UD2_B_344	65%	35%	0.135	0.938	0.93	1.69	2	12	4	0	100%	0.8923
3RUC_UD2_A_344	59%	37%	0.148	0.932	0.97	1.57	2	10	8	0	100%	0.8923
3RUC_UD2_D_344	56%	32%	0.142	0.913	0.97	1.81	3	11	5	0	100%	0.8923
3RUC_UD2_C_344	53%	35%	0.157	0.919	0.84	1.81	1	10	6	0	100%	0.8923
3LU1_UD2_B_344	72%	40%	0.135	0.96	0.92	1.46	1	8	3	0	100%	0.8923
8DQD_UD2_A_401	93%	35%	0.078	0.971	1.09	1.58	3	13	2	0	100%	1
8JJQ_UD2_A_401	92%	54%	0.08	0.969	0.63	1.15	-	7	4	0	100%	1
6WJA_UD2_A_402	90%	30%	0.088	0.972	1.25	1.67	3	5	0	0	100%	1
1OQM_UD2_D_528	89%	17%	0.096	0.974	1.93	1.82	7	11	6	0	100%	1
4D0T_UD2_A_1574	88%	30%	0.105	0.98	1.04	1.84	3	14	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.